Axogen Q3 net income more than triples year over year to $2.33 million; Q3 revenue rises 26% year over year to $75.83 million
Bitget2026/10/28 11:15- Axogen's third-quarter 2026 net income more than tripled year over year to $2.33 million, while revenue climbed 26% to $75.83 million.
- The acquisition of BioCircuit Technologies, developer of NerveTape, closed October 1.
- Full-year 2026 revenue guidance calls for at least $290 million, including at least $7 million from BioCircuit.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
Crypto prices
More
